ロード中...
Life-threatening acute acalculous cholecystitis in a patient with renal cell carcinoma treated by sunitinib: a case report
INTRODUCTION: Sunitinib, an oral multitargeted tyrosine kinase inhibitor, is widely used in the treatment of renal cell carcinoma and gastrointestinal stromal tumor and has had a variety of adverse events. However, sunitinib-related acute cholecystitis has been reported in only two patients with gas...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3307430/ https://ncbi.nlm.nih.gov/pubmed/22348690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-6-69 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|